Solution Spotlight with Quotient Sciences Accelerating development of spray dried dispersions for early phase clinical trials and beyond

3/14/2018 09:50 - 10:25

  • Benefits of spray-drying to address poor drug solubility
  • Fit-for-purpose and fit-for-phase systems in early clinical research
  • Effectively transitioning to solid oral dosage forms
  • Adaptive manufacturing “tailored” to the clinical study and patient recruitment
  • Overcoming challenges with highly potent molecules

Nikki Whitfield, Vice President CDMO Services, Quotient Sciences